Document is current
Any future updates will be listed below
-
Authors
Iwamoto, Takayuki
Nozaki, Yasutoshi
Inoue, Takanori
Suda, Takahiro
Mizumoto, Rui
Arimoto, Yuki
Ohta, Takashi
Yamaguchi, Shinjiro
Ito, Yoshiki
Sudo, Yoshiko
Yoshimura, Michiko
Kai, Machiko
Sasaki, Yoichi
Tahata, Yuki
Hikita, Hayato
Takehara, Tetsuo
Hagiwara, Hideki https://orcid.org/0000-0002-8361-1311
- License Information
-
More Information
Article History
Received: 10 July 2024
Accepted: 25 October 2024
First Online: 25 November 2024
Declarations
:
: Tetsuo Takehara has received research grants from Janssen Pharmaceutical K.K., Gilead Sciences, Inc., Abbie Inc., and Chugai Pharmaceutical Co., Ltd. Tetsuo Takehara and Hayato Hikita have received lecture fees from Gilead Sciences, Inc, Abbie Inc, and Chugai Pharmaceutical Co., Ltd. All other authors declare no conflict of interest.
: This study was approved by the Institutional Review Board of Kansai Rosai Hospital (Approval No. 23E041g) and Osaka University Graduate School of Medicine (Approval No. K23182) and conducted following the Declaration of Helsinki. All patients provided written informed consent for liver biopsy before and after treatment.
